Faeth Therapeutics, Inc.: MONTANOVA CAPITAL, LLC amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Montanova Capital, LLC amended its Schedule 13G filing for Faeth Therapeutics, Inc., disclosing a change in its beneficial ownership stake with the SEC under accession number 0000919574-26-007764. The filing, submitted to the regulator, updates the investment firm's previously reported position in the clinical-stage oncology company. The amendment signals a shift in Montanova's holdings, though the specific size and direction of the stake change were not detailed in the filing headline. Investors will watch for the full filing to confirm whether the adjustment reflects an increase or reduction in Montanova's position.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Montanova Capital, LLC, Faeth Therapeutics, Inc.